Facts in numbers
Some data on the development of diagnostic methods and exosome therapies in the world, involving private companies and government agencies.
0
Is the total amount of registered clinical trials (as of May/2023) involving exosomes on the NIH/USA registration platform (clinicaltrials.gov).
0
Is the current estimated number of world companies (2023) operating or developing products based on exosomes for diagnostic or therapeutic purposes.
0
years
Our team’s time of research in this field
0
Following development of different stages of clinical trials, estimated year of registration and market release of ConExo.
0
%
Is the expected world average annual growth rate (CAGR) for the exosome therapies market (2021-2026).
